title: Phase II trial with Brequinar (DUP-785, NSC 368390) in patients with metastatic colorectal cancer: a study of the Early Clinical Trials Group of the EORTC.
authors.affiliation: Institut Jules Bordet, Brussels, Belgium.
authors.forename: P F
authors.initials: PF
authors.lastname: Dodion
authors.forename: T
authors.initials: T
authors.lastname: Wagener
authors.forename: G
authors.initials: G
authors.lastname: Stoter
authors.forename: A
authors.initials: A
authors.lastname: Drozd
authors.forename: L M
authors.initials: LM
authors.lastname: Lev
authors.forename: T
authors.initials: T
authors.lastname: Skovsgaard
authors.forename: J
authors.initials: J
authors.lastname: Renard
authors.forename: F
authors.initials: F
authors.lastname: Cavalli
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy / Q000556:secondary*; D000328:Adult; D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001713:Biphenyl Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000473:pathology*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011798:Quinaldines
chemical_list: D000970:Antineoplastic Agents; D001713:Biphenyl Compounds; C046943:brequinar; D011798:Quinaldines